GWN Securities Inc. Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GWN Securities Inc. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, HoldingsChannel.com reports. The firm bought 538 shares of the medical equipment provider’s stock, valued at approximately $281,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC lifted its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock valued at $1,530,318,000 after purchasing an additional 53,383 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $488.80 on Tuesday. The stock has a fifty day moving average price of $566.38 and a 200-day moving average price of $531.96. The company has a market cap of $174.10 billion, a price-to-earnings ratio of 76.26, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ISRG shares. CICC Research started coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $610.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.